Some crossing action today,might get some news on just what the FDA want.
I spoke to an analyst covering this stock.
He has not heard of the FDA not giving any indication of why no pass in there letter.
Should know more soon and if not too negative he expects the share price to recover to pre FDA letter levels.
Heres hoping.
Regards,
